Annabel Samimy
Stock Analyst at Stifel
(3.34)
# 922
Out of 4,884 analysts
56
Total ratings
40.43%
Success rate
24.82%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Annabel Samimy
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
LGND Ligand Pharmaceuticals | Initiates: Buy | $143 | $113.30 | +26.21% | 1 | Apr 10, 2025 | |
PVLA Palvella Therapeutics | Initiates: Buy | $45 | $23.70 | +89.87% | 1 | Mar 26, 2025 | |
GPCR Structure Therapeutics | Initiates: Buy | $50 | $20.44 | +144.62% | 1 | Jan 8, 2025 | |
ALT Altimmune | Initiates: Buy | $18 | $4.90 | +267.35% | 1 | Jan 8, 2025 | |
IVA Inventiva | Maintains: Buy | $20 → $17 | $2.98 | +470.47% | 4 | Nov 22, 2024 | |
MBX MBX Biosciences | Initiates: Buy | $40 | $12.33 | +224.41% | 1 | Oct 8, 2024 | |
KMDA Kamada | Initiates: Buy | $18 | $7.74 | +132.56% | 1 | Jul 3, 2024 | |
PHAT Phathom Pharmaceuticals | Initiates: Buy | $24 | $8.91 | +169.36% | 1 | May 3, 2024 | |
RGNX REGENXBIO | Maintains: Buy | $40 | $8.62 | +364.04% | 2 | Apr 12, 2024 | |
VKTX Viking Therapeutics | Reiterates: Buy | $80 | $27.72 | +188.60% | 6 | Mar 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $230 | $109.92 | +109.24% | 8 | Mar 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 → $25 | $9.21 | +171.44% | 1 | Mar 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $18.97 | +84.50% | 1 | Oct 5, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $65 | $17.82 | +264.76% | 3 | Aug 29, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $700 → $275 | $5.25 | +5,138.10% | 4 | Jun 26, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $14.29 | +214.91% | 1 | Mar 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $8 | $0.81 | +892.56% | 1 | Nov 10, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $0.53 | +4,412.97% | 1 | Aug 24, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $20 | $29.63 | -32.50% | 1 | Apr 24, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $700 → $750 | $1.14 | +65,689.47% | 3 | Apr 16, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $25 → $24 | $32.07 | -25.16% | 7 | Apr 16, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $15 → $21 | $0.67 | +3,025.00% | 6 | Sep 18, 2019 |
Ligand Pharmaceuticals
Apr 10, 2025
Initiates: Buy
Price Target: $143
Current: $113.30
Upside: +26.21%
Palvella Therapeutics
Mar 26, 2025
Initiates: Buy
Price Target: $45
Current: $23.70
Upside: +89.87%
Structure Therapeutics
Jan 8, 2025
Initiates: Buy
Price Target: $50
Current: $20.44
Upside: +144.62%
Altimmune
Jan 8, 2025
Initiates: Buy
Price Target: $18
Current: $4.90
Upside: +267.35%
Inventiva
Nov 22, 2024
Maintains: Buy
Price Target: $20 → $17
Current: $2.98
Upside: +470.47%
MBX Biosciences
Oct 8, 2024
Initiates: Buy
Price Target: $40
Current: $12.33
Upside: +224.41%
Kamada
Jul 3, 2024
Initiates: Buy
Price Target: $18
Current: $7.74
Upside: +132.56%
Phathom Pharmaceuticals
May 3, 2024
Initiates: Buy
Price Target: $24
Current: $8.91
Upside: +169.36%
REGENXBIO
Apr 12, 2024
Maintains: Buy
Price Target: $40
Current: $8.62
Upside: +364.04%
Viking Therapeutics
Mar 15, 2024
Reiterates: Buy
Price Target: $80
Current: $27.72
Upside: +188.60%
Mar 15, 2024
Maintains: Buy
Price Target: $225 → $230
Current: $109.92
Upside: +109.24%
Mar 8, 2024
Reiterates: Buy
Price Target: $23 → $25
Current: $9.21
Upside: +171.44%
Oct 5, 2023
Initiates: Buy
Price Target: $35
Current: $18.97
Upside: +84.50%
Aug 29, 2023
Maintains: Buy
Price Target: $60 → $65
Current: $17.82
Upside: +264.76%
Jun 26, 2023
Downgrades: Hold
Price Target: $700 → $275
Current: $5.25
Upside: +5,138.10%
Mar 7, 2023
Initiates: Buy
Price Target: $45
Current: $14.29
Upside: +214.91%
Nov 10, 2022
Upgrades: Buy
Price Target: $8
Current: $0.81
Upside: +892.56%
Aug 24, 2021
Initiates: Buy
Price Target: $24
Current: $0.53
Upside: +4,412.97%
Apr 24, 2020
Initiates: Hold
Price Target: $20
Current: $29.63
Upside: -32.50%
Apr 16, 2020
Maintains: Buy
Price Target: $700 → $750
Current: $1.14
Upside: +65,689.47%
Apr 16, 2020
Maintains: Hold
Price Target: $25 → $24
Current: $32.07
Upside: -25.16%
Sep 18, 2019
Maintains: Hold
Price Target: $15 → $21
Current: $0.67
Upside: +3,025.00%